about
Theileria-induced constitutive IKK activation is independent of functional Hsp90IκB kinases increase Myc protein stability and enhance progression of breast cancer cellsA20-binding inhibitor of nuclear factor-kappaB (NF-kappaB)-2 (ABIN-2) is an activator of inhibitor of NF-kappaB (IkappaB) kinase alpha (IKKalpha)-mediated NF-kappaB transcriptional activityWhen ubiquitin meets NF-κB: a trove for anti-cancer drug developmentMechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infectionAnti-tumor activity of non-steroidal anti-inflammatory drugs: cyclooxygenase-independent targetsMechanisms of apoptosis by the tumor suppressor Par-4Roles of spatial parameters on the oscillation of nuclear NF-κB: computer simulations of a 3D spherical cellUBXD Proteins: A Family of Proteins with Diverse Functions in CancerTranscription Factors in the Cellular Response to Charged Particle ExposureA cell cycle regulatory network controlling NF-kappaB subunit activity and functionThe emerging roles of forkhead box (Fox) proteins in cancerTo NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate RegulatorAddressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicinAnticancer compound plumbagin and its molecular targets: a structural insight into the inhibitory mechanisms using computational approachesEffect of natural and semisynthetic pseudoguianolides on the stability of NF-κB:DNA complex studied by agarose gel electrophoresisASAP3 upregulation contributes to colorectal carcinogenesis and indicates poor survival outcomeObserving single cell NF-κB dynamics under stimulant concentration gradientTcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies.Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO.Colorectal cancer and NF-κB signaling pathwayReactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients.Arenamides A-C, cytotoxic NFkappaB inhibitors from the marine actinomycete Salinispora arenicola.Diet components can suppress inflammation and reduce cancer risk.A Boolean-based systems biology approach to predict novel genes associated with cancer: Application to colorectal cancer.IKKβ regulates the repair of DNA double-strand breaks induced by ionizing radiation in MCF-7 breast cancer cellsFijiolides A and B, inhibitors of TNF-alpha-induced NFkappaB activation, from a marine-derived sediment bacterium of the genus NocardiopsisNF-kappaB activation enhances cell death by antimitotic drugs in human prostate cancer cells.Constitutive non-canonical NFkappaB signaling in pancreatic cancer cellsIn vitro and in vivo studies on stilbene analogs as potential treatment agents for colon cancerDEAD-box helicase DP103 defines metastatic potential of human breast cancers.Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease.Nuclear Factor-κB modulates cellular glutathione and prevents oxidative stress in cancer cells.Laser scanning cytometry: principles and applications-an update.Investigation of Vietnamese plants for potential anticancer agents.Hit identification of IKKβ natural product inhibitor.MEKK3 expression correlates with nuclear factor kappa B activity and with expression of antiapoptotic genes in serous ovarian carcinoma.Towards the small and the beautiful: a small dibromotyrosine derivative from Pseudoceratina sp. sponge exhibits potent apoptotic effect through targeting IKK/NFκB signaling pathway.Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type.Nuclear factor-kappaB (NF-kappaB) mediates a protective response in cancer cells treated with inhibitors of fatty acid synthase.
P2860
Q24300863-415D018F-8836-4C6B-BB24-0A0B67A0BDBEQ24302544-8AE64E97-EDAF-448A-B677-E0708EBAD189Q24316467-9C1B5384-8EA4-4153-8642-3EB8FEB91454Q26827754-2073B1EC-4F00-4879-84A3-C4657133E09DQ27002467-4C7F6492-CA84-4E1E-AED3-4CD400072B15Q27004250-CB006B35-FB84-4520-9371-EA6A021BB4CEQ27011309-B162B689-B9D8-4BF9-A3F8-9E81836AC8A7Q27315527-32502BCA-A13B-4EC5-B899-0F8C79C08433Q28069036-91C12583-0D60-4ACA-9B95-03E995B99ADDQ28069717-90A8772D-4B8B-442B-B053-3698F5ABAC73Q28116296-E63FAEDB-1E61-47F9-B2F1-93CBBEC5F826Q28253741-BFB21FAD-A405-42CF-AFE5-26A994EEFBCFQ28386593-06A547F0-BC36-4369-8B80-B7C2A34397DAQ28476078-0DE6E9D0-63B4-452B-A089-729332E9719EQ28540187-EFA51F46-7658-49AA-985B-BBF1052A460DQ28543064-0A3EF373-4BD8-432A-BBFA-8036CDCF9F8AQ30008732-8996E9D3-7B17-4955-83F4-D8B60BD62362Q30509540-456DC58A-0A44-47B6-BE6D-D0FFB7C04509Q31040364-B6401F56-2BBF-41B1-A2A4-F0205AD9BC70Q33296431-EDD72767-0C50-47FF-84B8-85FE256DB1ABQ33596306-7AE80A5F-5A5A-4485-AA3C-6F05F511338EQ33637755-FB24E78A-5227-43BD-82A0-266FF921968DQ33721939-1835820D-3284-496F-A9C0-EC3DBF5A773AQ33758929-3524B43F-85D2-4AAC-9255-09B8109794C3Q33830172-E87F7100-15E5-426D-A921-A953FDF113A3Q33872159-6AAD0489-3677-43F9-A6D2-F8894ACFA410Q33982435-831CE4BA-B4CF-4C88-A8D3-43C37295B32FQ34013972-E7DFE669-5B59-49D7-B769-57D6968E7491Q34021737-1175F423-CEDB-4890-9A6F-332D08161DAEQ34054238-D55B7F47-259A-4275-817B-25FF8635A96DQ34117601-D3A1A3DE-A218-420E-BDAA-AAFE3603A998Q34205236-C18DC2B3-EB22-4E76-A647-8C720847F25DQ34209307-B79D19F5-9ADC-4D37-AB7F-FB95F0ED0844Q34425863-B06A2C8A-22F0-45FD-80BF-EE7B5EB31628Q34478640-B6DC5E65-80CB-484B-A65C-21C485895F1CQ34538026-16465091-D062-4638-A7EF-B2589E975F1EQ34700976-14EDB625-F2C6-4E5E-A706-9D8FEB27D728Q34996707-AD2EA2AF-157C-4B14-B762-52FE10AB07F3Q35051303-4A65BFF7-A073-4B62-B0A1-9CBF8380CFBAQ35213153-8114FAC5-DF45-4234-944D-889F1350CD9E
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
NF-kappaB and IKK as therapeutic targets in cancer
@ast
NF-kappaB and IKK as therapeutic targets in cancer
@en
NF-kappaB and IKK as therapeutic targets in cancer
@nl
type
label
NF-kappaB and IKK as therapeutic targets in cancer
@ast
NF-kappaB and IKK as therapeutic targets in cancer
@en
NF-kappaB and IKK as therapeutic targets in cancer
@nl
prefLabel
NF-kappaB and IKK as therapeutic targets in cancer
@ast
NF-kappaB and IKK as therapeutic targets in cancer
@en
NF-kappaB and IKK as therapeutic targets in cancer
@nl
P2093
P2860
P3181
P356
P1476
NF-kappaB and IKK as therapeutic targets in cancer
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/SJ.CDD.4401877
P407
P577
2006-05-01T00:00:00Z